Good manufacturing practice production of an off-the-shelf CD34+ progenitor-derived NK cell product with preserved anti-tumor functionality post-infusion in NOD/SCID/IL2Rgnull miceLaura Hooijmaijers, Harry Dolstra, Marcos Vidal-Manrique et al.|Cellular and Molecular Life Sciences|2025Cited by 6
Intraperitoneal infusion of stem cell-derived natural killer cells in recurrent epithelial ovarian cancer patients: Results of the phase 1 INTRO-01 trialJanneke S. Hoogstad‐van Evert, Harry Dolstra, Anniek B. van der Waart et al.|Gynecologic Oncology|2025Cited by 6